lazaros (@lazarostzelves) 's Twitter Profile
lazaros

@lazarostzelves

ID: 972235874

calendar_today26-11-2012 16:05:20

249 Tweet

100 Followers

191 Following

Tom Powles (@tompowles1) 's Twitter Profile Photo

Updated SUNRISE1 -TAR-200 has a CR rate 83% (50% at 12 months) in BCG unresponsive NMIBC. Impressive. Other single arm data for Il-15/ adenovival vectors are within the same range. Cross trial comparisons of modest sized single arm trials is tricky. #AUA25 time for randomisation?

Updated SUNRISE1 -TAR-200 has a CR rate 83% (50% at 12 months) in BCG unresponsive NMIBC. Impressive. Other single arm data for Il-15/ adenovival vectors are within the same range. Cross trial comparisons of modest sized single arm trials is tricky. #AUA25 time for randomisation?
Fernando GomezSancha (@fgomsan) 's Twitter Profile Photo

After a lazy period... I have uploaded a MiLEP (HoLEP performed with a 22 F enucleoscope & morcescope) case to my YouTube Channel... let me know what you think... youtu.be/D0s8sh5bwrE Felipe Figueiredo HoLEP 🇧🇷

Tom Powles (@tompowles1) 's Twitter Profile Photo

POTOMAC trial- Durvalumab + BCG shows positive results for DFS in high-risk NMIBC vs BCG alone. sasanlimab (CREST) also had an EFS advantage here: HR 0.68. Consistent results in early disease is compelling. IO tox is relevant in risk/benefit ratio. astrazeneca.com/media-centre/p…

POTOMAC trial- Durvalumab + BCG shows positive results for DFS in high-risk NMIBC vs BCG alone. sasanlimab (CREST) also had an EFS advantage here: HR 0.68. Consistent results in early disease is compelling. IO tox is relevant in risk/benefit ratio.   astrazeneca.com/media-centre/p…
European Urology (@euplatinum) 's Twitter Profile Photo

Review – Prostate Cancer : VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer by Veeru Kasivisvanathan et al Read the

Review – Prostate Cancer : VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer by Veeru Kasivisvanathan et al

Read the
Annals of Oncology (@annals_oncology) 's Twitter Profile Photo

🆕article in press: Pembrolizumab plus enzalutamide and androgen deprivation therapy vs placebo plus enzalutamide and androgen deprivation therapy for mHSPC: the randomized, double-blind, phase III KEYNOTE-991 study Christian Gratzke doi.org/10.1016/j.anno…

🆕article in press: Pembrolizumab plus enzalutamide and androgen  deprivation therapy vs placebo plus enzalutamide and androgen  deprivation therapy for mHSPC:  the randomized, double-blind, phase III KEYNOTE-991 study <a href="/cgratzke/">Christian Gratzke</a> 
doi.org/10.1016/j.anno…
Ege Can Serefoglu (@drserefoglu) 's Twitter Profile Photo

🚨 Our latest paper is out in European Urology We reviewed the evolving landscape of #ErectileDysfunction management—covering pharmacological, regenerative & surgical approaches. 📖 Read here: [na01.safelinks.protection.outlook.com/?url=https%3A%…] #ErectileDysfunction #Andrology #UroTwitter #MensHealth

🚨 Our latest paper is out in <a href="/EuropeanUrology/">European Urology</a> 
We reviewed the evolving landscape of #ErectileDysfunction management—covering pharmacological, regenerative &amp; surgical approaches.

📖 Read here: [na01.safelinks.protection.outlook.com/?url=https%3A%…]

#ErectileDysfunction #Andrology #UroTwitter #MensHealth
European Urology (@euplatinum) 's Twitter Profile Photo

Review - Testis Cancer: Epidemiology and Risk Factors for Testicular Cancer: A Systematic Review by Valentina Tateo et al Read the full article here: buff.ly/NGdPJLU Come back later to read the Editorial! #UroSoMe #MedTwitter #EditorsChoice #TestisCancer #EurUrol

Review - Testis Cancer: Epidemiology and Risk Factors for Testicular Cancer: A Systematic Review by <a href="/vale_tateo/">Valentina Tateo</a> et al

Read the full article here: buff.ly/NGdPJLU 

Come back later to read the Editorial!

#UroSoMe #MedTwitter #EditorsChoice #TestisCancer #EurUrol
BURST Urology (@bursturology) 's Twitter Profile Photo

🚨 PUBLICATION ALERT Our 🔥 hot-off the press 🔥 systematic review + meta-analysis (63 studies, >4000 patients) 📜 in Eur Urol Focus European Urology with new insights into ULTRASOUND 🔎for suspected #testiculartorsion 👨‍🦱 Read full paper 👉 authors.elsevier.com/a/1l5Fs_siPeZS… #UroSoMe

🚨 PUBLICATION ALERT

Our 🔥 hot-off the press 🔥 systematic review + meta-analysis (63 studies, &gt;4000 patients) 📜 in <a href="/EurUrolFocus/">Eur Urol Focus</a> <a href="/EUplatinum/">European Urology</a> with new insights into ULTRASOUND 🔎for suspected #testiculartorsion 👨‍🦱

Read full paper 👉
authors.elsevier.com/a/1l5Fs_siPeZS…

#UroSoMe
Juan Gómez Rivas (@jgomezrivas) 's Twitter Profile Photo

A new systematic review & meta-analysis explores the role of androgen receptor pathway inhibitor (ARPI) monotherapy across prostate cancer stages. •⚖️ Similar overall safety to ADT or ARPI+ADT combo •❤️‍🔥 Fewer hot flushes •⚠️ More breast-related side effects (pain &

A new systematic review &amp; meta-analysis explores the role of androgen receptor pathway inhibitor (ARPI) monotherapy across prostate cancer stages.

•⚖️ Similar overall safety to ADT or ARPI+ADT combo
•❤️‍🔥 Fewer hot flushes
•⚠️ More breast-related side effects (pain &amp;
JCM MDPI (@jcm_mdpi) 's Twitter Profile Photo

#mdpijcm 🚀#Highly_Cited_Paper🚀 Views 10697, Citations 31👏 #Urological Guidelines for #KidneyStones: Overview and Comprehensive Update 📌mdpi.com/2679364 by Mahir Akram et al. Andreas Skolarikos lazaros MDPI Medicine & Pharmacology

#mdpijcm
🚀#Highly_Cited_Paper🚀
Views 10697, Citations 31👏
#Urological Guidelines for #KidneyStones: Overview and Comprehensive Update
📌mdpi.com/2679364
by Mahir Akram et al. <a href="/SkolarikosAndre/">Andreas Skolarikos</a> <a href="/lazarostzelves/">lazaros</a>   <a href="/MediPharma_MDPI/">MDPI Medicine & Pharmacology</a>
Ron Barbosa MD FACS (@rbarbosa91) 's Twitter Profile Photo

Redo🧵 regarding PDS (polydioxanone) surgical sutures. For reasons that will become evident later, it is useful for me to revisit an old 🧵I posted about PDS 3 years ago. We will again go over the properties of PDS, its history, and what each of the sizes are used for. (1/ )

Redo🧵 regarding PDS (polydioxanone) surgical sutures.

For reasons that will become evident later, it is useful for me to revisit an old 🧵I posted about PDS 3 years ago.

We will again go over the properties of PDS, its history, and what each of the sizes are used for.
(1/ )
Veeru Kasi (@veerukasi) 's Twitter Profile Photo

The Wikipedia for landmark Urology research papers #LANDMARK. Level up your knowledge with the minimal effort. Includes key critical appraisal and very concise summaries for practising urologists. 👀 it OUT bursturology.com. Great job BURST Urology #BAUS25 European Society of Residents in Urology

The Wikipedia for landmark Urology research papers #LANDMARK. Level up your knowledge with the minimal effort. Includes key critical appraisal and very concise summaries for practising urologists. 👀 it OUT bursturology.com. Great job <a href="/BURSTurology/">BURST Urology</a> #BAUS25 <a href="/ESRUrology/">European Society of Residents in Urology</a>
Urologeman (Nariman Gadzhiev) (@urologeman) 's Twitter Profile Photo

🚨BREAKING: Just received footage of a new dinosaur species living in the human bladder. The little guy 🦖 was rescued and released back into the wild. Endourology never ceases to surprise. #urology #bladderdino

European Urology (@euplatinum) 's Twitter Profile Photo

🚨 NEW #PlatinumOpinion in European Urology by M. J. Roberts, Giorgio Gandaglia et al : 💡 Is extended pelvic lymph node dissection (ePLND) still justified in prostate cancer? 📉 No oncologic benefit in RCTs ⚠️ Up to 20% complication rate 🧬 PSMA PET reshapes staging 🔄 2024 EAU

🚨 NEW #PlatinumOpinion in European Urology by M. J. Roberts, <a href="/GGandaglia/">Giorgio Gandaglia</a> et al :

💡 Is extended pelvic lymph node dissection (ePLND) still justified in prostate cancer?

📉 No oncologic benefit in RCTs
⚠️ Up to 20% complication rate
🧬 PSMA PET reshapes staging

🔄 2024 EAU
Tom Powles (@tompowles1) 's Twitter Profile Photo

With the final analysis of the last of the 1st line metastatic clear cell RCC trials combination trials it’s still fair to say ‘pick one and use it well’. #GUARDSymposium2025 Ipi/nivo is less good at getting initial control but has less long term toxicity. Brian Rini, MD OncoAlert

With the final analysis of the last of the 1st line metastatic clear cell RCC trials combination trials it’s still fair to say ‘pick one and use it well’. #GUARDSymposium2025 Ipi/nivo is less good at getting initial control but has less long term toxicity. <a href="/brian_rini/">Brian Rini, MD</a> <a href="/OncoAlert/">OncoAlert</a>